Cleared Traditional

K810481 - VISUAL PATTERN REVERSAL GEN. & PHOTIC S.

K810481 is an FDA 510(k) clearance for VISUAL PATTERN REVERSAL GEN. & PHOTIC S., manufactured by Amplaid USA, Inc.. The device is a Class 2 Neurology device with product code GWE cleared through the Traditional 510(k) pathway after a 16-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1981
Decision
16d
Days
Class 2
Risk

K810481 is an FDA 510(k) clearance for the VISUAL PATTERN REVERSAL GEN. & PHOTIC S.. Classified as Stimulator, Photic, Evoked Response (product code GWE), Class II - Special Controls.

Submitted by Amplaid USA, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 11, 1981 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K810481

510(k) Number K810481 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 23, 1981
Decision Date March 11, 1981
Days to Decision 16 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
133d faster than avg
Panel avg: 149d · This submission: 16d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWE Device Classification - Class 2, Special Controls

Product Code GWE Stimulator, Photic, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWE Stimulator, Photic, Evoked Response

All 48
Devices cleared under the same product code (GWE) and FDA review panel - the closest regulatory comparables to K810481.
EVOKED 3500 POTENTIAL SYSTEM
K832084 · Tracor Northern, Inc. · Aug 1983
BIOLOGIC SYSTEM BL 101
K831047 · Bio-Logic Systems Corp. · May 1983
MODEL S10VS VISUAL STIMULATOR
K812061 · Grass Instrument Co. · Aug 1981
ESG-1 (EVOKED RESPONSE STIMULUS GENER)
K801671 · Neurodiagnostics, Inc. · Aug 1980
STIMULATOR MODEL SSS-1101
K791149 · Nihon Kohden America, Inc. · Sep 1979
STIMULATOR, NIC-106 VISUAL
K790570 · Nicolet Biomedical Instruments · May 1979